it is a dual GIP and GLP-1 receptor agonist that works through incretin-based mechanisms rather than central nervous system stimulation
Without insurance, brand-name drugs like Mounjaro can run between $950 to $1,200+ per month, depending on dose and availability
We have some literature so far that seems to suggest, again, resistance training is really helpful to mitigate some of that," said Cohen
However, despite substantial evidence supporting their use, GLP-1 RAs are not consistently adopted in clinical practice [16]
Does Medicare Cover Mounjaro (Tirzepatide)
At the highest approved dose of 15 mg , average weight loss exceeded that achieved with semaglutide by approximately 5.5 kg